Nebulised heparin as a treatment for COVID-19: Scientific rationale and a call for randomised evidence

Citation

van Haren PhD, F, Page, C, Laffey, J et al. 2020, 'Nebulised heparin as a treatment for COVID-19: Scientific rationale and a call for randomised evidence', Critical Care, vol. 24, pp. 1-11.

Year

2020

Fields of Research

  • Infectious Diseases
  • Respiratory Diseases
  • Intensive Care

Updated:  26 June 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers